Business Wire

Derains & Gharavi : Press Release on Behalf of Caratube International Oil Company LLP And Mr. Devincci Hourani

Del

The following is a statement from Derains & Gharavi, Caratube and Mr. Hourani’s legal representatives:

"On September 27, 2017, an ICSID Arbitral Tribunal, under auspices of the World Bank, composed of President Prof. Laurent Levy, Prof. Laurent Aynés and Prof. Jacques Salès, rendered the first Award ruling on the merits the Hourani family (including Messrs. Devincci Hourani, Issam Hourani (Khorani) and Kassem Omar)’s numerous claims against Kazakhstan, in favour of Caratube International Oil Company LLP (“Caratube”) finding Kazakhstan liable under Kazakh and international law for unlawful expropriation and ordered it to pay Caratube USD 39.2 million in damages, plus USD 1,207,757.44, and well over 10 million USD in interest ("ICSID Award").

The Hourani family had its business empire expropriated by Kazakhstan in 2008 and has ever since been the target of acts of intimidation and defamation by Kazakhstan worldwide, based on what it has claimed ever since to be pretenses whereas the underlying reason is simply that it was caught in between a family and political dispute between President Nazarbayev and his then son in law, the late Mr. Rakhat Aliyev, to whom the Houranis are related by marriage.

The Hourani family has since 2008 launched a number of arbitrations against Kazakhstan and has been preparing to seek compensation for the expropriation of their businesses. The ICSID Award is the very first Award ever that has ruled on the merits of any of these claims. It was in relation to a Contract for the Exploration and Production of Hydrocarbons dated May 27, 2002 entered into by Caratube with the Ministry of Energy and Mineral Resources.

The Tribunal found by majority decision, at paragraph 905 of the Award, that the termination of the Contract by the Ministry of Energy and Mineral Resources was unlawful and in breach of Kazakh and international law as Caratube was not adequately notified of any alleged breaches of Contract before termination, and that there was in any event no evidence that Caratube had materially breached any of its obligations.

The Tribunal further added, at paragraphs 924, 926, 927 and 934 of the Award, that the termination of the Contract was made as a result of the interference of the General Prosecutor by means of correspondence to the Ministry of Energy and Mineral Resources, which was acted on as an instruction to the Ministry to terminate Caratube’s Contract. It found that this constituted a sovereign interference in a private contract in violation of Kazakh and international law.

More, the Tribunal held, at paragraph 936 of the Award, that the real motivation behind the termination of the Contract was, as the Hourani family has been claiming since 2008 in relation to each and every one of their expropriated investments, not any allegedly deficient performance, but rather lied in the family and political context underlying the case, i.e. coinciding with the Hourani family’s falling out of favor of Kazakhstan. As the Tribunal put it at the same paragraph: “It was the Respondent’s sovereign act that caused [Caratube]’s loss of its existing rights under the Contract, rather than the latter’s alleged breaches of the Contract. In particular, considering the troubling facts (especially the chronology of the facts taken as a whole) underlying this case and the evidence on the record, a majority of the Tribunal considers that the Claimants have convincingly established that the real motivation behind the termination of the Contract was not [Caratube]’s allegedly deficient performance of the Contract, but rather lies in the family and political context underlying the case. While [Caratube]’s deficient performance of its contractual obligations might not have been approved by the Respondent, it was tolerated without any material consequences attached thereto until the year 2007, thus coinciding with the Hourani family’s falling out of favor with the Respondent.”

The holding of the tribunal, the first to ever rule on the merits of any of the takings by Kazakhstan of the Hourani family’s assets, is transposable to all of the takings that occurred under the same circumstances in violation of Kazakh and international law. Kazakhstan has similarly expropriated the Hourani family's airport, pharmaceutical company, poultry industry, media and many other assets, spent so far over USD 50,000,000 (including over 17,000,000 USD in the latest Caratube ruling only) in legal, expert and lobbying fees worldwide to justify the same via post facto allegations of the most errand kind that have aggravated the Hourani family's hardship.

The Houranis, businessmen only without any involvement ever in politics, are friends of Kazakhstan and its citizens and hope that this first ever judgment on the merits by an international tribunal under the auspices of the World Bank ruling under Kazakh and international will allow prompt and fair compensation for the taking of all of their assets and the closure of all claims in the interest of all parties.

The Award is publicly available at https://www.italaw.com/sites/default/files/case-documents/italaw9324.pdf. Further enquiries should be addressed to Caratube and Mr. Hourani’s legal representative, Dr. Hamid G. Gharavi, of the law firm Derains & Gharavi (Paris), by email hgharavi@derainsgharavi.com or phone + 33 1 40 55 51 00."

Contact information

Derains & Gharavi
Dr. Hamid G. Gharavi, + 33-1-40-55-51-00
hgharavi@derainsgharavi.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha